Literature DB >> 16357404

Acute pulmonary embolism: correlation of CT pulmonary artery obstruction index with blood gas values.

Zafiria M Metafratzi1, Miltos P Vassiliou, George C Maglaras, Froso G Katzioti, Stauros H Constantopoulos, Afroditi Katsaraki, Stauros C Efremidis.   

Abstract

OBJECTIVE: The purpose of our study was to investigate the relation between the pulmonary artery obstruction index assessed with helical CT and impairment in blood gases in patients with acute pulmonary embolism. SUBJECTS AND METHODS: Helical CT pulmonary angiography was performed in 78 patients who were suspected of having acute pulmonary embolism and selected as being free of underlying cardiopulmonary disease. Findings consistent with acute pulmonary embolism were observed in 34 patients. The severity was assessed by the pulmonary artery obstruction index, defined as Sigma (n x d), where n is the number of segmental arteries occluded and d is the degree of obstruction. Spearman's rank correlation coefficients were used to assess the correlation between the index of arterial obstruction and arterial partial pressure of oxygen (Pao(2)); alveolar-arterial difference in partial pressure of oxygen (Pao(2)-Pao(2)); arterial partial pressure of carbon dioxide (Paco(2)); and arterial oxygen saturation (Sao(2)). The statistical difference of the arterial blood gas values between the two groups of patients (those with and those without pulmonary embolism) was evaluated using the Mann-Whitney U test. Blood gases were comparatively evaluated below and above different index values (from 40% to 70%) and different Paco(2) values (25, 30, and 35 mm Hg) as possible indexes of embolism severity using the same test. The level of significance was set at 95% (p = 0.05).
RESULTS: The values of Pao(2), Sao(2), and Paco(2) were significantly lower (p = 0.024, p = 0.0062, and p = 0.000075, respectively) and the values of Pao(2)-Pao(2) were significantly higher (p = 0.0169) in the pulmonary embolism group than in the no-pulmonary-embolism group. A significant correlation was observed between the obstruction index and Pao(2) (r = -0.33, p = 0.05), Paco(2) (r = -0.34, p = 0.05), Pao(2)-Pao(2) (r = 0.39, p = 0.02), and Sao(2) (r = -0.35, p = 0.04). Using cutoff values for the pulmonary artery obstruction index of 40%, 50%, 60%, and 70%, we observed that Paco(2) and Pao(2)-Pao(2) differed significantly between above and below the 40% (p = 0.018 and p = 0.03), 50% (p = 0.0087 and p = 0.029), and 60% (p = 0.005 and p = 0.003) cutoffs. Pao(2) differed significantly for the cutoff values of 60% (p = 0.03) and 70% (p = 0.004). The same was observed for Sao(2) at 60% (p = 0.05) and 70% (p = 0.03). Comparisons for Paco(2) showed that a value of 30 mm Hg significantly separates levels of the pulmonary artery obstruction index (p = 0.002), with 78% sensitivity and 82% specificity indicating a pulmonary artery obstruction index greater than 50%.
CONCLUSION: In patients with acute pulmonary embolism but no other underlying cardiopulmonary disease, the severity of the pulmonary arterial tree obstruction assessed using the CT obstruction index is significantly correlated to the blood gas values. The strongest correlation was observed between the index and the Pao(2)-Pao(2). Furthermore, a Paco(2) value of 30 mm Hg or less is highly suggestive of an obstruction index of more than 50% of the arterial bed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357404     DOI: 10.2214/AJR.04.1320

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Relation between pulmonary embolus volume quantified by multidetector computed tomography and clinical status and outcome for patients with acute pulmonary embolism.

Authors:  Kei Nakada; Takemichi Okada; Hisato Osada; Norinari Honda
Journal:  Jpn J Radiol       Date:  2010-01-30       Impact factor: 2.374

2.  Study of clinical, radiological and echocardiographic features and correlation of Qanadli CT index with RV dysfunction and outcomes in pulmonary embolism.

Authors:  B S Praveen Kumar; D Rajasekhar; V Vanajakshamma
Journal:  Indian Heart J       Date:  2014-11-03

3.  Severity assessment of pulmonary embolism using dual energy CT - correlation of a pulmonary perfusion defect score with clinical and morphological parameters of blood oxygenation and right ventricular failure.

Authors:  Sven F Thieme; Nima Ashoori; Fabian Bamberg; Wieland H Sommer; Thorsten R C Johnson; Hanno Leuchte; Alexander Becker; Daniel Maxien; Andreas D Helck; Jürgen Behr; Maximilian F Reiser; Konstantin Nikolaou
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

4.  Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study.

Authors:  Yunfeng Zhang; Qixing Zhou; Ying Zou; Xiaolian Song; Shuanshuan Xie; Min Tan; Guoliang Zhang; Changhui Wang
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

5.  Relationship between Thrombosis Risk Factors, Clinical Symptoms, and Laboratory Findings with Pulmonary Embolism Diagnosis; a Cross-Sectional Study.

Authors:  Rama Bozorgmehr; Mehdi Pishgahi; Pegah Mohaghegh; Marziye Bayat; Parastou Khodadadi; Ahmadreza Ghafori
Journal:  Arch Acad Emerg Med       Date:  2019-07-23

6.  Evaluation of computed tomography obstruction index in guiding therapeutic decisions and monitoring percutanous catheter fragmentation in massive pulmonary embolism.

Authors:  Tongfu Yu; Mei Yuan; Qingbo Zhang; Haibing Shi; Dehang Wang
Journal:  J Biomed Res       Date:  2011-11

7.  Clinical update on pulmonary embolism.

Authors:  Serap Duru; Arif Keleşoğlu; Sadık Ardıç
Journal:  Arch Med Sci       Date:  2013-05-07       Impact factor: 3.318

8.  Prognostic value of lactates in relation to gas analysis and acid-base status in patients with pulmonary embolism.

Authors:  Kristina Galić; Danijel Pravdić; Zrinko Prskalo; Suzana Kukulj; Boris Starčević; Mladenka Vukojević
Journal:  Croat Med J       Date:  2018-08-31       Impact factor: 1.351

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.